Activities
Novel Reversal Agents to Safely and Effectively Treat Direct Oral Anticoagulant Bleeding: Education for the Health-System Pharmacist
0290-0000-21-245-H01-P
Apply the most recent evidence-based guidelines to the selection of direct oral anticoagulant (DOAC) reversal agents in reversal of major bleeding associated with the use of DOACs.
1.00
Advancements in Emerging COVID-19 Vaccines: Identifying the Barriers to Widespread Administration and the Role of the Pharmacist
0290-0000-21-246-H06-P
This activity offers pharmacists the most up-to-date information about the emerging vaccines so they may address any fears or skepticism that patients may have to work toward herd immunity.
1.00
Initiating Antivirals for the Prevention and Treatment of the Influenza Virus: Highlights of the Latest Safety and Efficacy Data for Pharmacists
0290-0000-21-250-H01-P
Recognize patient populations at greatest risk for influenza-related complications
0.75
Reducing and Preventing Influenza-Related Morbidity and Mortality Through Vaccinations: Educating Patients During the COVID-19 Pandemic
0290-0000-21-251-H06-P
Explain the pathogenesis of the influenza virus infection and most common modes of transmission
1.00